Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$57.56 - $82.54 $314,565 - $451,081
-5,465 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$72.5 - $100.68 $130,500 - $181,224
-1,800 Reduced 24.78%
5,465 $425,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $655,593 - $901,223
7,265 New
7,265 $693,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Dcm Advisors, LLC Portfolio

Follow Dcm Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.